Microdosing: functional over intoxicated

TL;DR

• Typical window: 1-5 mg THC or 5-20 mg CBD per dose.
• Goal: sub-perceptual effect with therapeutic benefit.
• Solowij 2019: 2.5 mg THC improves pain without meaningful cognitive impact.
• Slower CB1 down-regulation = slower tolerance build-up.

Why less is often more

The THC dose-response is biphasic: a small dose can ease anxiety and sleep, a high dose flips it (anxiogenic). Microdosing stays inside the therapeutic window.

Microdosing: effect below the threshold of intoxication

With THC, microdosing refers to single doses of about 1 to 2.5 mg — amounts that, for most people, lie below the threshold of a noticeable intoxication. The background to this is the biphasic dose-response curve: low doses can have anxiolytic and activating effects, whereas higher doses trigger the exact opposite, increasing anxiety or restlessness. With THC, more is not automatically more effect, but often a different one.

In practice, it is less about a fixed number and more about a procedure: starting with a minimal dose for two to three weeks, recording the effect in writing, and only then adjusting in small steps. Without a log, it is impossible to tell the difference between the actual effect, daily form, and expectations — at low doses, this is precisely the greatest source of error.

• THC microdose typically 1–2.5 mg per dose
• Biphasic curve: higher dose can reverse the effect
• Stay at one dose for two to three weeks, then adjust
• Written log: dose, timing, effect, side effects

CBD microdosing and the Swiss framework

For CBD, the usual amounts are higher — typically 5 to 20 mg per dose, distributed throughout the day — and the safety profile is more favorable; the WHO classifies CBD as well-tolerated with low abuse potential. Because CBD products are freely available in Switzerland below the 1 % threshold, microdosing is practically feasible here without legal risk. For THC microdoses, legal access remains restricted to medically prescribed cannabis and approved pilot projects.

Swiss classification: Products with less than 1% total THC (THC + THCA × 0.877) are not narcotics and are freely available; above this, the Narcotics Act applies. For road traffic, the method of consumption is irrelevant — the decisive factor is the detection limit value of 1.5 µg THC per litre of blood, which leads to unfitness to drive. Medical cannabis has been prescribable by doctors without an exceptional permit from the BAG since August 2022.

Precise dosing in everyday life: comparing administration forms

When it comes to microdosing, choosing the right form of consumption is a decisive factor in the success or failure of the entire application. While the classic smoking of cannabis flowers makes exact dosing in the milligram range absolutely impossible due to fluctuating combustion temperatures and uneven distribution of active ingredients, standardized extracts and tinctures offer the urgently needed precision. Oils administered drop by drop allow users to adjust the dose step-by-step in the range of tenths of a milligram in everyday life. In this way, a reproducible and reliable effect can be achieved without undesirable psychoactive effects disrupting the daily routine or performance.

A technological alternative for precise administration is the targeted vaporisation of flowers using a high-quality vaporiser, provided the device features degree-accurate temperature control. However, the depth of inhalation and breath-holding times must also be closely monitored to precisely control the actual absorption of active ingredients into the body. Nevertheless, oral or sublingual consumption of oils remains the most reliable method in everyday life for most users. Absorption of the active ingredients via the mucous membrane is more even, which effectively minimises unpredictable fluctuations in effect and dosing errors that occur more frequently during inhalation.

• Oils and tinctures enable drop-by-drop dosing in the milligram range.
• Inhalation via vaporiser requires precise temperature control and standardised flowers.
• Smoking is unsuitable for microdosing due to uncontrollable losses of active ingredients.
• Sublingual absorption via the oral mucosa ensures a faster onset of action than purely oral consumption.

Legal sourcing channels in Switzerland: prescriptions and pilot trials

Anyone wishing to legally practice THC-based microdosing in Switzerland quickly encounters tight legal limits in the conventional recreational sector, as products with a total THC content of over one percent fall under the Narcotics Act. Since August 2022, however, legal access via the medical route has been considerably simplified. Doctors can now prescribe medical cannabis directly and without prior exceptional authorisation from the FOPH. This enables patients to obtain quality-assured tinctures with a precisely declared active ingredient content in a controlled manner from specialised Swiss pharmacies, which is what makes safe and exact dosing in everyday life possible in the first place.

Another option for healthy consumers is provided by the scientific pilot trials currently being conducted in various Swiss cities such as Zurich, Basel, or Bern. Participants in these time-limited studies can legally purchase regulated cannabis products in selected pharmacies or social clubs. For microdosing, the oils or lower-dose products offered within these projects are of particular interest for testing the desired micro-amounts in a controlled manner in everyday life. In this way, consumption can be scientifically monitored while consistently eliminating the risk of illegal and contaminated products from the black market.

• Since August 2022, medical cannabis can be prescribed directly by doctors without an exceptional permit from the FOPH.
• Standardised THC oils are legally sourced through Swiss pharmacies.
• Scientific pilot trials offer legal access for research purposes in the recreational sector.
• Products from the black market carry the risk of fluctuating active ingredient levels and dangerous contamination.

Risks and the strict Swiss road traffic regulations

Despite the minimal dosage, microdosing is by no means free of risks and far-reaching legal consequences in everyday life. The greatest practical risk for Swiss consumers lies in the area of road traffic. Since a strict zero-tolerance policy applies in Switzerland with a statutory THC detection limit of 1.5 micrograms per litre of blood, even the regular consumption of micro-amounts almost inevitably leads to incapacity to drive in the legal sense. The human body metabolises THC very individually, which is why the active ingredient can accumulate in fatty tissue and exceed the limit value even days after the last intake.

In addition to the legal aspects, pharmacological interactions in the body must also be carefully considered. Cannabinoids are metabolised via the liver enzymes of the cytochrome P450 system, which can massively influence the effect and breakdown of other medications taken at the same time. Even though psychoactive side effects are extremely rare with genuine micro-amounts, individuals with relevant pre-existing conditions or those on long-term medication must consult a medical professional beforehand. This is the only way to reliably rule out undesired interactions and health risks prior to self-experimentation.

• A strict zero-tolerance policy applies in Swiss road traffic with a limit value of 1.5 µg/L of blood.
• Due to the accumulation effect, THC can accumulate in fatty tissue even at low doses.
• There are potential interactions with medications via the cytochrome P450 enzyme system of the liver.
• When using non-standardised DIY devices, there is a risk of unintentional incorrect dosing.

The importance of terpenes and the entourage effect

In practice, microdosing is not just about the isolated THC or CBD molecule, but about the complex interaction of all the plant's constituents. Terpene, the natural aromatic compounds in cannabis, play a crucial role in modulating the overall effect. This phenomenon, known in specialist circles as the entourage effect, ensures that micro-amounts of a full-spectrum tincture often show a significantly more balanced and profound effect than pure isolates. The terpenes contained can positively influence the permeability of the blood-brain barrier and alter binding to the receptors of the endocannabinoid system.

For the practical application of microdosing, this means that the targeted choice of cannabis strain or the specific terpene profile significantly determines the therapeutic focus. While extracted oils with a high myrcene content tend to have a calming and sleep-promoting effect, profiles containing limonene or pinene can support mental concentration and focus in everyday life. Users should therefore preferably look for high-quality full-spectrum products when purchasing legal CBD oils or medical THC preparations. This is the only way to benefit from these synergistic effects in order to achieve the desired effect even with minimal doses.

• The entourage effect describes the synergistic interaction of cannabinoids and terpenes.
• Terpenes such as myrcene, limonene or pinene modulate the effect of cannabinoids in the brain.
• Full-spectrum extracts are usually superior to isolates when microdosing due to their more complex effects.
• Individual reactions depend heavily on the specific terpene profile of the product used.

FAQ